Drag a card by its title · ⚙ to size, swap or remove

The company

MediWound Ltd. -

MDWD · Nasdaq

Health CareBiotechnologyNot moving yet

MDWD stood above a rising 150-day average in 1 of the last 52 weekly readings, and has been out of that trend for the last 44 weeks. It is 14.1% below that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 44
Industry in uptrend: 16% -15 in 4 wk
Insider buys, 12 months: $285K
Insider sales, 12 months: $164K
Officials’ trades on record: 0
Institutions holding: 78 (+5)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 1 of 52 weeks.

20 Apr – 19 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months4

Sale orders, 12 months3

Buyers · sellers3 · 2

Who	Did	Shares	Traded
Samuel RubinsteinDirector	sold	525at $12.72	1 Sep 2026filed 2 Sep 2026
Samuel RubinsteinDirector	bought	525at $12.62	1 Sep 2026filed 2 Sep 2026
Shmuel HessCOO & Chief Commercial Officer	sold	1,979at $12.72	27 Aug 2026filed 28 Aug 2026
Shmuel HessCOO & Chief Commercial Officer	sold	1,979at $13.13	27 Aug 2026filed 28 Aug 2026
Shmuel HessCOO & Chief Commercial Officer	sold	1,865at $13.00	26 Aug 2026filed 28 Aug 2026
Nachum ShamirDirector	bought	175at $13.98	3 Jun 2026filed 4 Jun 2026
Nachum ShamirDirector	bought	5,825at $14.00	3 Jun 2026filed 4 Jun 2026
David Morton FoxDirector	bought	1,730at $14.23	1 Jun 2026filed 2 Jun 2026
David Morton FoxDirector	bought	10at $14.23	1 Jun 2026filed 2 Jun 2026
David Morton FoxDirector	bought	1,797at $14.00	1 Jun 2026filed 2 Jun 2026
Samuel RubinsteinDirector	bought	150at $14.33	29 May 2026filed 1 Jun 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders78+5 on the quarter

New · exited18 · 12

Reported value$75.4M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
INVESTOR ABunchanged · filed 14 Aug 2026	872,093$12.8M	00.0%
Yelin Lapidot Holdings Management Ltd.reduced · filed 3 Aug 2026	758,169$11.1M	-4,648−0.6%
Rosalind Advisors, Inc.unchanged · filed 14 Aug 2026	749,054$11.0M	00.0%
BlackRock, Inc.added · filed 7 Aug 2026	525,929$7.7M	+80,095+18.0%
SPHERA FUNDS MANAGEMENT LTD.unchanged · filed 14 Aug 2026	273,192$4.0M	00.0%
Silverberg Bernstein Capital Management LLCadded · filed 7 Jul 2026	228,137$3.4M	+28,132+14.1%
STATE STREET CORPadded · filed 7 Aug 2026	168,669$2.5M	+24,899+17.3%
UBS Group AGreduced · filed 13 Aug 2026	155,922$2.3M	-3,869−2.4%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026	141,041$2.1M	+19,083+15.6%
Point72 Asset Management, L.P.reduced · filed 14 Aug 2026	129,248$1.9M	-46,231−26.3%